|
Originally published In Press as doi:10.1074/jbc.M106434200 on August 8, 2001
J. Biol. Chem., Vol. 276, Issue 41, 37993-38001, October 12, 2001
Tumor Necrosis Factor- -converting Enzyme (ADAM17) Mediates the
Cleavage and Shedding of Fractalkine (CX3CL1)*
Kyle J.
Garton §,
Peter J.
Gough §,
Carl P.
Blobel¶,
Gillian
Murphy ,
David R.
Greaves**,
Peter J.
Dempsey , and
Elaine W.
Raines §§
From the Department of Pathology, University of
Washington, Harborview Medical Center, Seattle, Washington 98104, ¶ Memorial Sloan-Kettering Cancer Center,
New York, New York 10021, School of Biological Sciences,
University of East Anglia, Norwich NR4 7TJ, United Kingdom,
** Sir William Dunn School of Pathology, University of
Oxford, Oxford OX1 3RE, United Kingdom, and
 Pacific Northwest Research Institute,
Seattle, Washington 98122
Fractalkine (CX3CL1) is an unusual
member of the chemokine family that is synthesized with its chemokine
domain at the end of a mucin-rich, transmembrane stalk. This
membrane-bound localization allows fractalkine to function as an
adhesion molecule for cells bearing its receptor, CX3CR1. In addition,
fractalkine can be proteolytically released from the cell surface,
generating a soluble molecule that functions as a chemoattractant
similar to the other members of the chemokine family. In this study, we
have examined the mechanisms that regulate the conversion between these
two functionally distinct forms of fractalkine. We demonstrate that under normal conditions fractalkine is synthesized as an intracellular precursor that is rapidly transported to the cell surface where it
becomes a target for metalloproteinase-dependent cleavage
that causes the release of a fragment containing the majority of the fractalkine extracellular domain. We show that the cleavage of fractalkine can be markedly enhanced by stimulating cells with phorbol
12-myristate 13-acetate (PMA), and we identify tumor necrosis factor- converting enzyme (TACE; ADAM17) as the protease responsible for this PMA-induced fractalkine release. In addition, we provide data
showing that TACE-mediated fractalkine cleavage occurs at a site
distinct from the dibasic juxtamembrane motif that had been suggested
previously based on protein sequence homologies. The identification of
TACE as a major protease responsible for the conversion of fractalkine
from a membrane-bound adhesion molecule to a soluble chemoattractant
will provide new information for understanding the physiological
function of this chemokine.
*
This work was supported by National Institutes of Health
Grants HL18645 (to E. W. R) and DK59778 (to P. J. D.), the Paul G. Allen Foundation for Medical Research (to K. J. G), the American Heart Association (to P. J. G), and the British Heart Foundation (to
D. R. G).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Both authors contributed equally to this work.
§§
To whom correspondence should be addressed: Dept. of Pathology,
Harborview Medical Center, 325 9th Ave., Box 359791, Seattle, WA
98104-2499. Tel.: 206-341-5410; Fax: 206-341-5416; E-mail: ewraines@u.washington.edu.
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. R. Koenen, J. Pruessmeyer, O. Soehnlein, L. Fraemohs, A. Zernecke, N. Schwarz, K. Reiss, A. Sarabi, L. Lindbom, T. M. Hackeng, et al.
Regulated release and functional modulation of junctional adhesion molecule A by disintegrin metalloproteinases
Blood,
May 7, 2009;
113(19):
4799 - 4809.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Sullivan, J. L. Pardieck, D. Doran, Y. Zhang, J.-X. She, and J. S. Pollock
Greater fractalkine expression in mesenteric arteries of female spontaneously hypertensive rats compared with males
Am J Physiol Heart Circ Physiol,
April 1, 2009;
296(4):
H1080 - H1088.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. E. White and D. R. Greaves
Fractalkine: one chemokine, many functions
Blood,
January 22, 2009;
113(4):
767 - 768.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Landsman, L. Bar-On, A. Zernecke, K.-W. Kim, R. Krauthgamer, E. Shagdarsuren, S. A. Lira, I. L. Weissman, C. Weber, and S. Jung
CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival
Blood,
January 22, 2009;
113(4):
963 - 972.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Hartl, C. H. He, B. Koller, C. A. Da Silva, R. Homer, C. G. Lee, and J. A. Elias
Acidic Mammalian Chitinase Is Secreted via an ADAM17/Epidermal Growth Factor Receptor-dependent Pathway and Stimulates Chemokine Production by Pulmonary Epithelial Cells
J. Biol. Chem.,
November 28, 2008;
283(48):
33472 - 33482.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Hermand, F. Pincet, S. Carvalho, H. Ansanay, E. Trinquet, M. Daoudi, C. Combadiere, and P. Deterre
Functional Adhesiveness of the CX3CL1 Chemokine Requires Its Aggregation: ROLE OF THE TRANSMEMBRANE DOMAIN
J. Biol. Chem.,
October 31, 2008;
283(44):
30225 - 30234.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Ishida, T. Hayashi, T. Goto, A. Kimura, S. Akimoto, N. Mukaida, and T. Kondo
Essential Involvement of CX3CR1-Mediated Signals in the Bactericidal Host Defense during Septic Peritonitis
J. Immunol.,
September 15, 2008;
181(6):
4208 - 4218.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. E. Cardona, M. Li, L. Liu, C. Savarin, and R. M. Ransohoff
Chemokines in and out of the central nervous system: much more than chemotaxis and inflammation
J. Leukoc. Biol.,
September 1, 2008;
84(3):
587 - 594.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Popovic, Y. Laumonnier, L. Burysek, T. Syrovets, and T. Simmet
Thrombin-induced expression of endothelial CX3CL1 potentiates monocyte CCL2 production and transendothelial migration
J. Leukoc. Biol.,
July 1, 2008;
84(1):
215 - 223.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Hyakudomi, T. Matsubara, R. Hyakudomi, T. Yamamoto, S. Kinugasa, A. Yamanoi, R. Maruyama, and T. Tanaka
Increased Expression of Fractalkine is Correlated with a Better Prognosis and an Increased Number of Both CD8+ T Cells and Natural Killer Cells in Gastric Adenocarcinoma
Ann. Surg. Oncol.,
June 1, 2008;
15(6):
1775 - 1782.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Zhao, A. De, Z. Hu, J. Li, S. M. Mulders, M. D. Sollewijn Gelpke, E.-K. Duan, and A. J. W. Hsueh
Gonadotropin Stimulation of Ovarian Fractalkine Expression and Fractalkine Augmentation of Progesterone Biosynthesis by Luteinizing Granulosa Cells
Endocrinology,
June 1, 2008;
149(6):
2782 - 2789.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. K. Bhavsar, M. B. Sukkar, N. Khorasani, K.-Y. Lee, and K. F. Chung
Glucocorticoid suppression of CX3CL1 (fractalkine) by reduced gene promoter recruitment of NF-{kappa}B
FASEB J,
June 1, 2008;
22(6):
1807 - 1816.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Holdt, J. Thiery, J. L. Breslow, and D. Teupser
Increased ADAM17 mRNA Expression and Activity Is Associated With Atherosclerosis Resistance in LDL-Receptor Deficient Mice
Arterioscler. Thromb. Vasc. Biol.,
June 1, 2008;
28(6):
1097 - 1103.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Pachot, M.-A. Cazalis, F. Venet, F. Turrel, C. Faudot, N. Voirin, J. Diasparra, N. Bourgoin, F. Poitevin, B. Mougin, et al.
Decreased Expression of the Fractalkine Receptor CX3CR1 on Circulating Monocytes as New Feature of Sepsis-Induced Immunosuppression
J. Immunol.,
May 1, 2008;
180(9):
6421 - 6429.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. L. Jamieson, S. Shimizu, J. A. D'Ambrosio, O. Meucci, and A. Fatatis
CX3CR1 Is Expressed by Prostate Epithelial Cells and Androgens Regulate the Levels of CX3CL1/Fractalkine in the Bone Marrow: Potential Role in Prostate Cancer Bone Tropism
Cancer Res.,
March 15, 2008;
68(6):
1715 - 1722.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Liu, Y.-R. A. Yu, J. A. Spencer, A. E. Johnson, C. T. Vallanat, A. M. Fong, C. Patterson, and D. D. Patel
CX3CR1 Deficiency Impairs Dendritic Cell Accumulation in Arterial Intima and Reduces Atherosclerotic Burden
Arterioscler. Thromb. Vasc. Biol.,
February 1, 2008;
28(2):
243 - 250.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Ali and V. Knauper
Phorbol Ester-induced Shedding of the Prostate Cancer Marker Transmembrane Protein with Epidermal Growth Factor and Two Follistatin Motifs 2 Is Mediated by the Disintegrin and Metalloproteinase-17
J. Biol. Chem.,
December 28, 2007;
282(52):
37378 - 37388.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Mizutani, T. Sakurai, T. Shibata, K. Uchida, J. Fujita, R. Kawashima, Y. I. Kawamura, N. Toyama-Sorimachi, T. Imai, and T. Dohi
Dose-Dependent Differential Regulation of Cytokine Secretion from Macrophages by Fractalkine
J. Immunol.,
December 1, 2007;
179(11):
7478 - 7487.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Charbonneau, K. Harper, F. Grondin, M. Pelmus, P. P. McDonald, and C. M. Dubois
Hypoxia-inducible Factor Mediates Hypoxic and Tumor Necrosis Factor {alpha}-induced Increases in Tumor Necrosis Factor-{alpha} Converting Enzyme/ADAM17 Expression by Synovial Cells
J. Biol. Chem.,
November 16, 2007;
282(46):
33714 - 33724.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Horiuchi, T. Miyamoto, H. Takaishi, A. Hakozaki, N. Kosaki, Y. Miyauchi, M. Furukawa, J. Takito, H. Kaneko, K. Matsuzaki, et al.
Cell Surface Colony-Stimulating Factor 1 Can Be Cleaved by TNF-{alpha} Converting Enzyme or Endocytosed in a Clathrin-Dependent Manner
J. Immunol.,
November 15, 2007;
179(10):
6715 - 6724.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Barlic and P. M. Murphy
Chemokine regulation of atherosclerosis
J. Leukoc. Biol.,
August 1, 2007;
82(2):
226 - 236.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Barlic, Y. Zhang, and P. M. Murphy
Atherogenic Lipids Induce Adhesion of Human Coronary Artery Smooth Muscle Cells to Macrophages by Up-regulating Chemokine CX3CL1 on Smooth Muscle Cells in a TNF{alpha}-NF{kappa}B-dependent Manner
J. Biol. Chem.,
June 29, 2007;
282(26):
19167 - 19176.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Hundhausen, A. Schulte, B. Schulz, M. G. Andrzejewski, N. Schwarz, P. von Hundelshausen, U. Winter, K. Paliga, K. Reiss, P. Saftig, et al.
Regulated Shedding of Transmembrane Chemokines by the Disintegrin and Metalloproteinase 10 Facilitates Detachment of Adherent Leukocytes
J. Immunol.,
June 15, 2007;
178(12):
8064 - 8072.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. R. Chinnery, M. J. Ruitenberg, G. W. Plant, E. Pearlman, S. Jung, and P. G. McMenamin
The Chemokine Receptor CX3CR1 Mediates Homing of MHC class II-Positive Cells to the Normal Mouse Corneal Epithelium
Invest. Ophthalmol. Vis. Sci.,
April 1, 2007;
48(4):
1568 - 1574.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. Dean and C. M. Overall
Proteomics Discovery of Metalloproteinase Substrates in the Cellular Context by iTRAQTM Labeling Reveals a Diverse MMP-2 Substrate Degradome
Mol. Cell. Proteomics,
April 1, 2007;
6(4):
611 - 623.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M Brueckmann and M Borggrefe
Therapeutic potential of fractalkine: a novel approach to metastatic colon cancer
Gut,
March 1, 2007;
56(3):
314 - 316.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S Vitale, B Cambien, B F Karimdjee, R Barthel, P Staccini, C Luci, V Breittmayer, F Anjuere, A Schmid-Alliana, and H Schmid-Antomarchi
Tissue-specific differential antitumour effect of molecular forms of fractalkine in a mouse model of metastatic colon cancer
Gut,
March 1, 2007;
56(3):
365 - 372.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Simionescu
Implications of Early Structural-Functional Changes in the Endothelium for Vascular Disease
Arterioscler. Thromb. Vasc. Biol.,
February 1, 2007;
27(2):
266 - 274.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Durkan, R. T. Alexander, G.-Y. Liu, M. Rui, G. Femia, and L. A. Robinson
Expression and Targeting of CX3CL1 (Fractalkine) in Renal Tubular Epithelial Cells
J. Am. Soc. Nephrol.,
January 1, 2007;
18(1):
74 - 83.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Lauro, M. Catalano, F. Trettel, F. Mainiero, M. T. Ciotti, F. Eusebi, and C. Limatola
The Chemokine CX3CL1 Reduces Migration and Increases Adhesion of Neurons with Mechanisms Dependent on the beta1 Integrin Subunit
J. Immunol.,
December 1, 2006;
177(11):
7599 - 7606.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Ancuta, J. Wang, and D. Gabuzda
CD16+ monocytes produce IL-6, CCL2, and matrix metalloproteinase-9 upon interaction with CX3CL1-expressing endothelial cells.
J. Leukoc. Biol.,
November 1, 2006;
80(5):
1156 - 1164.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Faure, C. Cerini, P. Paul, Y. Berland, F. Dignat-George, and P. Brunet
The uremic solute p-cresol decreases leukocyte transendothelial migration in vitro
Int. Immunol.,
October 1, 2006;
18(10):
1453 - 1459.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Liu, S. Patil, M. Rojas, A. M. Fong, S. S. Smyth, and D. D. Patel
CX3CR1 Deficiency Confers Protection From Intimal Hyperplasia After Arterial Injury
Arterioscler. Thromb. Vasc. Biol.,
September 1, 2006;
26(9):
2056 - 2062.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Barlic, Y. Zhang, J. F. Foley, and P. M. Murphy
Oxidized Lipid-Driven Chemokine Receptor Switch, CCR2 to CX3CR1, Mediates Adhesion of Human Macrophages to Coronary Artery Smooth Muscle Cells Through a Peroxisome Proliferator-Activated Receptor {gamma}-Dependent Pathway
Circulation,
August 22, 2006;
114(8):
807 - 819.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J Plumb, S McQuaid, A K Cross, J Surr, G Haddock, R A. Bunning, and M N Woodroofe
Upregulation of ADAM-17 expression in active lesions in multiple sclerosis
Multiple Sclerosis,
August 1, 2006;
12(4):
375 - 385.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Wang and H. S. Sul
Ectodomain Shedding of Preadipocyte Factor 1 (Pref-1) by Tumor Necrosis Factor Alpha Converting Enzyme (TACE) and Inhibition of Adipocyte Differentiation.
Mol. Cell. Biol.,
July 1, 2006;
26(14):
5421 - 5435.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Ohtsu, P. J. Dempsey, and S. Eguchi
ADAMs as mediators of EGF receptor transactivation by G protein-coupled receptors
Am J Physiol Cell Physiol,
July 1, 2006;
291(1):
C1 - C10.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. R. Green, K. H. Han, Y. Chen, F. Almazan, I. F. Charo, Y. I. Miller, and O. Quehenberger
The CC Chemokine MCP-1 Stimulates Surface Expression of CX3CR1 and Enhances the Adhesion of Monocytes to Fractalkine/CX3CL1 via p38 MAPK.
J. Immunol.,
June 15, 2006;
176(12):
7412 - 7420.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. J. Garton, P. J. Gough, and E. W. Raines
Emerging roles for ectodomain shedding in the regulation of inflammatory responses
J. Leukoc. Biol.,
June 1, 2006;
79(6):
1105 - 1116.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Chabot, J. S. Wagner, S. Farrant, and M. R. Neutra
TLRs Regulate the Gatekeeping Functions of the Intestinal Follicle-Associated Epithelium
J. Immunol.,
April 1, 2006;
176(7):
4275 - 4283.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. F. Charo and R. M. Ransohoff
The Many Roles of Chemokines and Chemokine Receptors in Inflammation
N. Engl. J. Med.,
February 9, 2006;
354(6):
610 - 621.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. S. Smookler, F. F. Mohammed, Z. Kassiri, G. S. Duncan, T. W. Mak, and R. Khokha
Cutting Edge: Tissue Inhibitor of Metalloproteinase 3 Regulates TNF-Dependent Systemic Inflammation
J. Immunol.,
January 15, 2006;
176(2):
721 - 725.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Suzuki, T. Nanki, T. Imai, H. Kikuchi, S. Hirohata, H. Kohsaka, and N. Miyasaka
Inhibition of CX3CL1 (Fractalkine) Improves Experimental Autoimmune Myositis in SJL/J Mice
J. Immunol.,
November 15, 2005;
175(10):
6987 - 6996.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kikuchi, S. Andarini, H. Xin, K. Gomi, Y. Tokue, Y. Saijo, T. Honjo, A. Watanabe, and T. Nukiwa
Involvement of Fractalkine/CX3CL1 Expression by Dendritic Cells in the Enhancement of Host Immunity against Legionella pneumophila
Infect. Immun.,
September 1, 2005;
73(9):
5350 - 5357.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Quehenberger
Thematic Review Series: The Immune System and Atherogenesis. Molecular mechanisms regulating monocyte recruitment in atherosclerosis
J. Lipid Res.,
August 1, 2005;
46(8):
1582 - 1590.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Mifune, H. Ohtsu, H. Suzuki, H. Nakashima, E. Brailoiu, N. J. Dun, G. D. Frank, T. Inagami, S. Higashiyama, W. G. Thomas, et al.
G Protein Coupling and Second Messenger Generation Are Indispensable for Metalloprotease-dependent, Heparin-binding Epidermal Growth Factor Shedding through Angiotensin II Type-1 Receptor
J. Biol. Chem.,
July 15, 2005;
280(28):
26592 - 26599.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J.R. Singh, J. C. Mason, E. A. Lidington, D. R. Edwards, R. K. Nuttall, R. Khokha, V. Knauper, G. Murphy, and J. Gavrilovic
Cytokine stimulated vascular cell adhesion molecule-1 (VCAM-1) ectodomain release is regulated by TIMP-3
Cardiovasc Res,
July 1, 2005;
67(1):
39 - 49.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Soond, B. Everson, D. W. H. Riches, and G. Murphy
ERK-mediated phosphorylation of Thr735 in TNF{alpha}-converting enzyme and its potential role in TACE protein trafficking
J. Cell Sci.,
June 1, 2005;
118(11):
2371 - 2380.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Buckley, F. N. Rouhani, M. Kaler, B. Adamik, F. I. Hawari, and S. J. Levine
Amino-terminal TACE prodomain attenuates TNFR2 cleavage independently of the cysteine switch
Am J Physiol Lung Cell Mol Physiol,
June 1, 2005;
288(6):
L1132 - L1138.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Fabre-Lafay, S. Garrido-Urbani, N. Reymond, A. Goncalves, P. Dubreuil, and M. Lopez
Nectin-4, a New Serological Breast Cancer Marker, Is a Substrate for Tumor Necrosis Factor-{alpha}-converting Enzyme (TACE)/ADAM-17
J. Biol. Chem.,
May 20, 2005;
280(20):
19543 - 19550.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G.-Y. Liu, V. Kulasingam, R. T. Alexander, N. Touret, A. M. Fong, D. D. Patel, and L. A. Robinson
Recycling of the Membrane-anchored Chemokine, CX3CL1
J. Biol. Chem.,
May 20, 2005;
280(20):
19858 - 19866.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Chandrasekar, S. Mummidi, W. C. Claycomb, R. Mestril, and M. Nemer
Interleukin-18 Is a Pro-hypertrophic Cytokine That Acts through a Phosphatidylinositol 3-Kinase-Phosphoinositide-dependent Kinase-1-Akt-GATA4 Signaling Pathway in Cardiomyocytes
J. Biol. Chem.,
February 11, 2005;
280(6):
4553 - 4567.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. P. Sanderson, S. N. Erickson, P. J. Gough, K. J. Garton, P. T. Wille, E. W. Raines, A. J. Dunbar, and P. J. Dempsey
ADAM10 Mediates Ectodomain Shedding of the Betacellulin Precursor Activated by p-Aminophenylmercuric Acetate and Extracellular Calcium Influx
J. Biol. Chem.,
January 21, 2005;
280(3):
1826 - 1837.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M Hasegawa, S Sato, T Echigo, Y Hamaguchi, M Yasui, and K Takehara
Up regulated expression of fractalkine/CX3CL1 and CX3CR1 in patients with systemic sclerosis
Ann Rheum Dis,
January 1, 2005;
64(1):
21 - 28.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Teupser, S. Pavlides, M. Tan, J.-C. Gutierrez-Ramos, R. Kolbeck, and J. L. Breslow
Major reduction of atherosclerosis in fractalkine (CX3CL1)-deficient mice is at the brachiocephalic artery, not the aortic root
PNAS,
December 21, 2004;
101(51):
17795 - 17800.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Bolovan-Fritts, R. N. Trout, and S. A. Spector
Human Cytomegalovirus-Specific CD4+-T-Cell Cytokine Response Induces Fractalkine in Endothelial Cells
J. Virol.,
December 1, 2004;
78(23):
13173 - 13181.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. B. Sukkar, R. Issa, S. Xie, U. Oltmanns, R. Newton, and K. F. Chung
Fractalkine/CX3CL1 production by human airway smooth muscle cells: induction by IFN-{gamma} and TNF-{alpha} and regulation by TGF-{beta} and corticosteroids
Am J Physiol Lung Cell Mol Physiol,
December 1, 2004;
287(6):
L1230 - L1240.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Barlic, D. H. McDermott, M. N. Merrell, J. Gonzales, L. E. Via, and P. M. Murphy
Interleukin (IL)-15 and IL-2 Reciprocally Regulate Expression of the Chemokine Receptor CX3CR1 through Selective NFAT1- and NFAT2-dependent Mechanisms
J. Biol. Chem.,
November 19, 2004;
279(47):
48520 - 48534.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Levine
Mechanisms of Soluble Cytokine Receptor Generation
J. Immunol.,
November 1, 2004;
173(9):
5343 - 5348.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Weber, A. Schober, and A. Zernecke
Chemokines: Key Regulators of Mononuclear Cell Recruitment in Atherosclerotic Vascular Disease
Arterioscler. Thromb. Vasc. Biol.,
November 1, 2004;
24(11):
1997 - 2008.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Zheng, P. Saftig, D. Hartmann, and C. Blobel
Evaluation of the Contribution of Different ADAMs to Tumor Necrosis Factor {alpha} (TNF{alpha}) Shedding and of the Function of the TNF{alpha} Ectodomain in Ensuring Selective Stimulated Shedding by the TNF{alpha} Convertase (TACE/ADAM17)
J. Biol. Chem.,
October 8, 2004;
279(41):
42898 - 42906.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Thathiah, M. Brayman, N. Dharmaraj, J. J. Julian, E. L. Lagow, and D. D. Carson
Tumor Necrosis Factor {alpha} Stimulates MUC1 Synthesis and Ectodomain Release in a Human Uterine Epithelial Cell Line
Endocrinology,
September 1, 2004;
145(9):
4192 - 4203.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Shulby, N. G. Dolloff, M. E. Stearns, O. Meucci, and A. Fatatis
CX3CR1-Fractalkine Expression Regulates Cellular Mechanisms Involved in Adhesion, Migration, and Survival of Human Prostate Cancer Cells
Cancer Res.,
July 15, 2004;
64(14):
4693 - 4698.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Li and H. Fan
Loss of Ectodomain Shedding Due to Mutations in the Metalloprotease and Cysteine-rich/Disintegrin Domains of the Tumor Necrosis Factor-{alpha} Converting Enzyme (TACE)
J. Biol. Chem.,
June 25, 2004;
279(26):
27365 - 27375.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. V. Bax, A. J. Messent, J. Tart, M. van Hoang, J. Kott, R. A. Maciewicz, and M. J. Humphries
Integrin {alpha}5{beta}1 and ADAM-17 Interact in Vitro and Co-localize in Migrating HeLa Cells
J. Biol. Chem.,
May 21, 2004;
279(21):
22377 - 22386.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Abel, C. Hundhausen, R. Mentlein, A. Schulte, T. A. Berkhout, N. Broadway, D. Hartmann, R. Sedlacek, S. Dietrich, B. Muetze, et al.
The Transmembrane CXC-Chemokine Ligand 16 Is Induced by IFN-{gamma} and TNF-{alpha} and Shed by the Activity of the Disintegrin-Like Metalloproteinase ADAM10
J. Immunol.,
May 15, 2004;
172(10):
6362 - 6372.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Daoudi, E. Lavergne, A. Garin, N. Tarantino, P. Debre, F. Pincet, C. Combadiere, and P. Deterre
Enhanced Adhesive Capacities of the Naturally Occurring Ile249-Met280 Variant of the Chemokine Receptor CX3CR1
J. Biol. Chem.,
May 7, 2004;
279(19):
19649 - 19657.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Gough, K. J. Garton, P. T. Wille, M. Rychlewski, P. J. Dempsey, and E. W. Raines
A Disintegrin and Metalloproteinase 10-Mediated Cleavage and Shedding Regulates the Cell Surface Expression of CXC Chemokine Ligand 16
J. Immunol.,
March 15, 2004;
172(6):
3678 - 3685.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.-P. Xu, Y. Ding, J. Ling, Z. Dong, and F.-S. X. Yu
Wound-Induced HB-EGF Ectodomain Shedding and EGFR Activation in Corneal Epithelial Cells
Invest. Ophthalmol. Vis. Sci.,
March 1, 2004;
45(3):
813 - 820.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Cruz, B. T. Frank, S. T. Edwards, P. F. Dazin, J. J. Peschon, and K. C. Fang
Tumor Necrosis Factor-{alpha}-converting Enzyme Controls Surface Expression of c-Kit and Survival of Embryonic Stem Cell-derived Mast Cells
J. Biol. Chem.,
February 13, 2004;
279(7):
5612 - 5620.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Shimaoka, T. Nakayama, N. Fukumoto, N. Kume, S. Takahashi, J. Yamaguchi, M. Minami, K. Hayashida, T. Kita, J. Ohsumi, et al.
Cell surface-anchored SR-PSOX/CXC chemokine ligand 16 mediates firm adhesion of CXC chemokine receptor 6-expressing cells
J. Leukoc. Biol.,
February 1, 2004;
75(2):
267 - 274.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Chandrasekar, S. Bysani, and S. Mummidi
CXCL16 Signals via Gi, Phosphatidylinositol 3-Kinase, Akt, I{kappa}B Kinase, and Nuclear Factor-{kappa}B and Induces Cell-Cell Adhesion and Aortic Smooth Muscle Cell Proliferation
J. Biol. Chem.,
January 30, 2004;
279(5):
3188 - 3196.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Vitale, A. Schmid-Alliana, V. Breuil, M. Pomeranz, M.-A. Millet, B. Rossi, and H. Schmid-Antomarchi
Soluble Fractalkine Prevents Monocyte Chemoattractant Protein-1-Induced Monocyte Migration via Inhibition of Stress-Activated Protein Kinase 2/p38 and Matrix Metalloproteinase Activities
J. Immunol.,
January 1, 2004;
172(1):
585 - 592.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Umehara, E. T. Bloom, T. Okazaki, Y. Nagano, O. Yoshie, and T. Imai
Fractalkine in Vascular Biology: From Basic Research to Clinical Disease
Arterioscler. Thromb. Vasc. Biol.,
January 1, 2004;
24(1):
34 - 40.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Barlic, J. M. Sechler, and P. M. Murphy
IL-15 and IL-2 oppositely regulate expression of the chemokine receptor CX3CR1
Blood,
November 15, 2003;
102(10):
3494 - 3503.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. P. Umland, C. G. Garlisi, H. Shah, Y. Wan, J. Zou, K. E. Devito, W.-M. Huang, E. L. Gustafson, and R. Ralston
Human ADAM33 Messenger RNA Expression Profile and Post-Transcriptional Regulation
Am. J. Respir. Cell Mol. Biol.,
November 1, 2003;
29(5):
571 - 582.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
F F Mohammed, D S Smookler, and R Khokha
Metalloproteinases, inflammation, and rheumatoid arthritis
Ann Rheum Dis,
November 1, 2003;
62(90002):
ii43 - 47.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Hahn, A. Pischitzis, S. Roesmann, M. K. Hansen, B. Leuenberger, U. Luginbuehl, and E. E. Sterchi
Phorbol 12-Myristate 13-Acetate-induced Ectodomain Shedding and Phosphorylation of the Human Meprin{beta} Metalloprotease
J. Biol. Chem.,
October 31, 2003;
278(44):
42829 - 42839.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Matthews, B. Schuster, S. Schutze, I. Bussmeyer, A. Ludwig, C. Hundhausen, T. Sadowski, P. Saftig, D. Hartmann, K.-J. Kallen, et al.
Cellular Cholesterol Depletion Triggers Shedding of the Human Interleukin-6 Receptor by ADAM10 and ADAM17 (TACE)
J. Biol. Chem.,
October 3, 2003;
278(40):
38829 - 38839.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. J. Garton, P. J. Gough, J. Philalay, P. T. Wille, C. P. Blobel, R. H. Whitehead, P. J. Dempsey, and E. W. Raines
Stimulated Shedding of Vascular Cell Adhesion Molecule 1 (VCAM-1) Is Mediated by Tumor Necrosis Factor-{alpha}-converting Enzyme (ADAM 17)
J. Biol. Chem.,
September 26, 2003;
278(39):
37459 - 37464.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Walcheck, S. R. Alexander, C. A. St. Hill, and E. Matala
ADAM-17-independent shedding of L-selectin
J. Leukoc. Biol.,
September 1, 2003;
74(3):
389 - 394.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Contin, V. Pitard, T. Itai, S. Nagata, J.-F. Moreau, and J. Dechanet-Merville
Membrane-anchored CD40 Is Processed by the Tumor Necrosis Factor-{alpha}-converting Enzyme: IMPLICATIONS FOR CD40 SIGNALING
J. Biol. Chem.,
August 29, 2003;
278(35):
32801 - 32809.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Hundhausen, D. Misztela, T. A. Berkhout, N. Broadway, P. Saftig, K. Reiss, D. Hartmann, F. Fahrenholz, R. Postina, V. Matthews, et al.
The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion
Blood,
August 15, 2003;
102(4):
1186 - 1195.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Borroto, S. Ruiz-Paz, T. V. de la Torre, M. Borrell-Pages, A. Merlos-Suarez, A. Pandiella, C. P. Blobel, J. Baselga, and J. Arribas
Impaired Trafficking and Activation of Tumor Necrosis Factor-{alpha}-converting Enzyme in Cell Mutants Defective in Protein Ectodomain Shedding
J. Biol. Chem.,
July 3, 2003;
278(28):
25933 - 25939.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. Silverman, D. O. Zamora, Y. Pan, P. V. Texeira, S.-H. Baek, S. R. Planck, and J. T. Rosenbaum
Constitutive and Inflammatory Mediator-Regulated Fractalkine Expression in Human Ocular Tissues and Cultured Cells
Invest. Ophthalmol. Vis. Sci.,
April 1, 2003;
44(4):
1608 - 1615.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Thathiah, C. P. Blobel, and D. D. Carson
Tumor Necrosis Factor-alpha Converting Enzyme/ADAM 17 Mediates MUC1 Shedding
J. Biol. Chem.,
January 24, 2003;
278(5):
3386 - 3394.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. F. Seals and S. A. Courtneidge
The ADAMs family of metalloproteases: multidomain proteins with multiple functions
Genes & Dev.,
January 1, 2003;
17(1):
7 - 30.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T Seifert, B C Kieseier, S Ropele, S Strasser-Fuchs, F Quehenberger, F Fazekas, and H-P Hartung
TACE mRNA expression in peripheral mononuclear cells precedes new lesions on MRI in multiple sclerosis
Multiple Sclerosis,
December 1, 2002;
8(6):
447 - 451.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Hintz, A. J. Rassias, K. Wardwell, M. L. Moss, P. M. Morganelli, P. A. Pioli, A. L. Givan, P. K. Wallace, M. P. Yeager, and P. M. Guyre
Endotoxin induces rapid metalloproteinase-mediated shedding followed by up-regulation of the monocyte hemoglobin scavenger receptor CD163
J. Leukoc. Biol.,
October 1, 2002;
72(4):
711 - 717.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Nishimura, H. Umehara, T. Nakayama, O. Yoneda, K. Hieshima, M. Kakizaki, N. Dohmae, O. Yoshie, and T. Imai
Dual Functions of Fractalkine/CX3C Ligand 1 in Trafficking of Perforin+/Granzyme B+ Cytotoxic Effector Lymphocytes That Are Defined by CX3CR1 Expression
J. Immunol.,
June 15, 2002;
168(12):
6173 - 6180.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. J. Williams
Stalking the Chemokine
Am. J. Respir. Crit. Care Med.,
May 15, 2002;
165(10):
1350 - 1351.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Balabanian, A. Foussat, P. Dorfmuller, I. Durand-Gasselin, F. Capel, L. Bouchet-Delbos, A. Portier, A. Marfaing-Koka, R. Krzysiek, A.-C. Rimaniol, et al.
CX3C Chemokine Fractalkine in Pulmonary Arterial Hypertension
Am. J. Respir. Crit. Care Med.,
May 15, 2002;
165(10):
1419 - 1425.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Ludwig, T. Berkhout, K. Moores, P. Groot, and G. Chapman
Fractalkine Is Expressed by Smooth Muscle Cells in Response to IFN-{gamma} and TNF-{alpha} and Is Modulated by Metalloproteinase Activity
J. Immunol.,
January 15, 2002;
168(2):
604 - 612.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-L. Tsou, C. A. Haskell, and I. F. Charo
Tumor Necrosis Factor-alpha -converting Enzyme Mediates the Inducible Cleavage of Fractalkine
J. Biol. Chem.,
November 21, 2001;
276(48):
44622 - 44626.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|